North America Checkpoint Inhibitors Market Outlook 2016-2021

Posted by rohan on November 1st, 2017

North America Checkpoint Inhibitors Market was worth USD 1.82 billion in 2016 and is expected to reach USD 6.22 billion by 2021 with a CAGR of 27.8 %.

Checkpoint Inhibitors are drugs which blocks certain proteins produced by immune system or cancer cells. These proteins help cancer cells escape the immune system but by blocking these proteins immune system is able to kill cancer cells better. This is a method of treatment available in Immunotherapy.

Rising Prevalence of cancer, and increasing funding and government support towards developing new drugs are some of the factors driving the growth of the market However, high expense involved in R&D activities is one of the major factors restricting the growth of the market.

North America Checkpoint Inhibitors Market is segmented based on Drug type and Application. Based on Drug type, market is segmented into PD-1 inhibitors, PD-L1 inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, others. Based on Application, market is segmented into Lung cancer, Renal cancer, Blood cancer, Bladder Cancer, Hodgkin lymphoma, Melanoma, Others. CTLA-4 Segment holds the highest share accounting for almost 94 % of the overall market. However, this segment is expected to lose some of its market to PD-1 inhibitors segment during the forecast period as majority of new treatments is based on PD-1 inhibitors.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-checkpoint-inhibitors-market-2178/request-sample

Geographically, market is further segmented into US and Canada. North America dominates the global market owing the relatively high clinical trials and funding available in this region.

Some of the key players in the North America checkpoint inhibitors market are Merck & Co., Inc., Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical Co., Ltd., Juno Therapeutics, Novartis International AG, and Kite Pharma.

Market Segmentation         

1) Drug Type                                                   

• Introduction                                           
• PD-1 inhibitors                                       
• PD-L1 inhibitors                                     
• CTLA-4                                      
• Chimeric Antigen Receptor T-cell                                 
• Others                                     
• Y-o-Y Growth Analysis, By Drug Type                                           
• Market Attractiveness Analysis, By Drug Type                                         
• Market Share Analysis, By Drug Type                                          

2) Application                                                 

• Introduction                                           
• Lung cancer                                            
• Renal cancer                                           
• Blood cancer                                          
• Bladder Cancer                                      
• Hodgkin lymphoma     
• Melanoma          
• Others 
• Y-o-Y Growth Analysis, By Application                                         
• Market Attractiveness Analysis, By Application                                   
• Market Share Analysis, By Application 

The North America Checkpoint Inhibitors Market study offers the following deliverables:

• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of Drug Type and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases